Dr. Kong from the University of IL has developed microparticles that create fibrin gels with desirable properties for wound healing products, drug delivery, and...
Dr. Kong from the University of IL has developed microparticles that create fibrin gels with desirable properties for wound healing products, drug delivery, and diagnostic tools. When blood clots it forms fibrin gel networks to close wounds temporarily for more permanent healing to take place. A significant problem with artificially-made fibrin gel networks is that they can be difficult to tune to attain desirable gelation rate and rigidity. The microparticles developed by Dr. Kong solve this problem by releasing thrombin in response to H2O2 to make gels with tunable, desirable properties.
Benefits
Encapsulating thrombin and MnO2 nanosheets allows for decoupling of gelation rate and gel rigidity.
Applications
This technology may be used for nano- or microparticles for drug delivery, biological gels for biomedical applications, or bleeding control/wound management.
Dr. Pablo Perez-Pinera has developed a method to divide prime editing tools into smaller components that are small enough to be delivered in adeno-associated viruses, an...
Dr. Pablo Perez-Pinera has developed a method to divide prime editing tools into smaller components that are small enough to be delivered in adeno-associated viruses, an FDA-approved vehicle for therapeutic use. Prime editors have recently shown great promise as gene editing tools with greater specificity and fewer off-target effects than existing CRISPR-Cas based methods. This technology has potential as a research tool as well as a therapeutic strategy.
Dr. Jeffrey Moore along with colleagues at Northwestern University has developed new nonproteinogenic substrates for use in a system that uses genetic reprogramming to...
Dr. Jeffrey Moore along with colleagues at Northwestern University has developed new nonproteinogenic substrates for use in a system that uses genetic reprogramming to create polymers. The system allows translation of polymers using substrates not used for protein synthesis. Presently over 200 substrates have been discovered, Dr. Moore has found over 40 new substrates. This technology allows for the creation of polypeptides and sequence-defined polymers in vitro and in vivo.
Dr. Thomas Gaj has developed a novel prime editor based on a Staphylococcus aureus Cas9 ortholog. Furthermore, he has developed split intein versions of the prime editing...
Dr. Thomas Gaj has developed a novel prime editor based on a Staphylococcus aureus Cas9 ortholog. Furthermore, he has developed split intein versions of the prime editing tools that are small enough to be dual-delivered in adeno-associated viruses, an FDA-approved vehicle for therapeutic use. This invention has been shown to improve targeting capability of the prime editors by several fold. Prime editors have recently shown great promise as gene editing tools with greater specificity and fewer off-target effects than existing CRISPR-Cas based methods. This technology has potential as a research tool as well as a therapeutic strategy.
